ZnO nanoparticles (NPs) Similarly, we demonstrate that needle-like NP morphologies enhance toxicity by apparently frustrating cellular uptake. To limit toxicity, ZnO NPs with non-acicular morphologies and coatings that only weakly interact with cellular membranes are recommended.
Table of Contents Graphic Introduction
The widespread use of nanoparticles (NPs) in industry and consumer products has led to an intense research effort into the effects of engineered NPs on human health and the environment. Zinc oxide (ZnO) NPs are one of the materials that have been extensively studied because of their use in cosmetic preparations, especially in sun cream. Recent research has demonstrated that ZnO is likely to dissolve and undergo phase transformations in aqueous environments, typically forming nanoparticulate compounds of lower solubility (zinc-phosphates, -carbonates, -sulphides and/or -iron hydroxides). [1] [2] [3] Dissolution of ZnO NPs and the re-precipitation as zinc carbonates and phosphates in different cell culture media has also been suggested; with the phosphate concentration of the media having a major effect on the equilibrium Zn 2+ levels in solution. 4, 5 As such, a careful assessment of the effect of solution chemistry on the physico-chemical properties of ZnO should be carried out as part of any complete nanotoxicology study.
Since ZnO NPs are prone to dissolution, 2, 6, 7 it has been suggested that the released free Zn 2+ ions are responsible for the observed toxicity, including damage to DNA via the generation of radical oxygen species (ROS). [8] [9] [10] For instance, Song et al. showed that the concentration of soluble zinc in the supernatant of a complete cell medium (Roswell Park Memorial Institute, RPMI 1640 medium supplemented with 10% fetal serum albumin) after centrifugation was about 10 g/mL. 9 They suggested that this zinc fraction is the Zn 2+ released by dissolution of ZnO NPs and assert that the dissolved Zn 2+ contributed to about 50% of the observed cell death in vitro, where ROS levels in the cell were proposed to be mainly due to a cytotoxic response to Zn 2+ inside the cell. The difference in toxicity between different ZnO particles was attributed to the non-dissolved particles. 9 Other reports, however, suggest that ROS are generated at the surface of ZnO NPs (e.g., 11 ) or that ZnO NPs are directly taken up by cells, increasing the intracellular Zn 2+ concentration to toxic levels not achieved by extra cellular exposure to similar concentration of soluble zinc salts. [12] [13] [14] This latter effect is supported by a report that direct NP-cell contact is required to generate toxicity within human cancer cells. 15 Also studies in vivo have started to address the role of ZnO dissolution. Cho et al. show that intratracheal instillation of ZnO NPs into the lungs of rats results in rapid pH-dependent dissolution of the ZnO in phagosomes and a toxic response consistent with the release of Zn 2+ . 16 Sharma et al. fed mice 300 mg ZnO/kg for 14 consecutive days and detected an accumulation of Zn 2+ in the liver, which was associated with significant oxidative stress. 17 To fully determine toxicity of NPs, it is now well established that in vitro toxicity assays need adjustments and that detailed physico-chemical characterisation of the NPs is required to cross-reference results for different sources of NPs. [18] [19] [20] [21] [22] [23] Ultimately, the toxicity of engineered NPs in general is dependent on the morphology, size (including hydrodynamic agglomeration state) and coating of the particles. 19 For ZnO NPs, the additional dissolution kinetics are also likely to depend on the morphology, size, hydrodynamic agglomeration and coating of the particles as well as the composition and conditions of the medium the particles are suspended in. As such, it is possible that much of the uncertainty described above regarding the mechanism of ZnO NP toxicity is due to variation in dissolution kinetics.
After an initial cell cytotoxicity screen of six different Zn NPs (Supplementary Information, Figure S1 , Table S1 ) we have undertaken a systematic study of three different ZnO NP types (polymer coated, uncoated equiaxed and needle-like ZnO NPs). Here, we report on the equilibrium dissolution, dissolution rates and re-precipitation of these ZnO NPs in CO 2 buffered cell culture media and go on to compare the cytotoxicity and DNA damage to investigate the role of released, free Zn 2+ . We also investigate cellular uptake and interaction with lipid membranes to highlight the role of the less rapidly dissolved NP fraction. The results identify three mechanisms by which ZnO NPs can cause cytotoxicity.
Experimental Procedures
ZnO nanoparticles and characterisation NP sample 1, EZ-1; commercial, NanoTek® NPs were bought via Alfa Aesar (Cat #: 45409;
the exact formulation and coating details were unreported). These ZnO NPs have a coating in order to disperse well in liquids; ATR-FTIR indicates the coating to be an aliphatic polyether (Supplementary Information, Figure S2 and S3). NP sample 2, EZ-2; commercial, uncoated NPs were bought from Alfa Aesar (Cat #: 44533). NP sample 3, EZ-3; nano-needles were hydrothermally synthesized from ZnCl 2 and Na 2 CO 3 dissolved in distilled water (140°C for 12 h). The final precipitates obtained were separated from the liquid phase and washed 6 times with distilled water.
Physico-chemical characterisation
Transmission electron microscopy (TEM) was conducted on an FEI Tecnai F20 FEG-TEM operated at 200 kV and equipped with a Gatan Orius SC600A CCD camera and an Oxford
Instruments 80mm X-Max SDD detector. ZnO NPs were prepared for TEM by placing a drop of the NPs suspended in alcohol onto a copper TEM grid coated with a holey carbon support film (Agar Scientific Ltd.) and allowed to air dry before examination in the TEM.
Dynamic Light Scattering (DLS) and Zeta Potential measurements were performed using a
Malvern Zetasizer Nano ZS in water and (serum-free) cell culture media. Each sample was analyzed 5 times with the average result presented. Powder X-ray Diffraction (XRD) was undertaken using a Bruker D8 powder X-ray diffractometer fitted with a Vantec detector and using a Cu-K source (1.540 Å shown to be phase pure by XRD with a primary equiaxed particle morphology ~70 nm in diameter. When dispersed in water they coalesced to agglomerates with a hydrodynamic diameter of ~140 nm and when dispersed in water plus a background electrolyte (at 0.1 ionic strength) they coalesced to agglomerates with a hydrodynamic diameter of ~1100 nm.
Cell culture, viability and genotoxicity assays A549 (human lung alveolar carcinoma) cells and HT29 (human colon cancer) cells (SigmaAldrich) were cultured in DMEM containing 10% foetal bovine serum (Lonza, Slough, UK) with 0.5% penicillin/streptomycin. HaCaT (human keratinocyte) cells (gifted from within the University of Leeds) were cultured in RPMI media (Gibco, Paisley, Scotland) containing 10% foetal bovine serum (Lonza, Slough, UK) with 0.5% penicillin/streptomycin. All cell lines were incubated at 37 C in humidified 5% CO 2 until they were approaching confluence, when they were harvested using trypsin-ethylenediamine tetra-acetic acid (EDTA) and then re-seeded.
Effects of ZnO NPs on the viability and genetic fidelity of the cells were evaluated using the MTT (thiazolyl blue tetrazolium bromide) and Comet assays, respectively, using a modified protocol to that described previously. 25 Suspensions of EZ-2 and EZ-3 were made in water (1 mg/mL and 10 mg/mL) and bath-sonicated (Decon, FS minor) for 30 min before adding them to the cell media in appropriate concentrations. We note that in this assay the cells have been incubated with ZnO NPs for 24 h in the absence of foetal bovine serum. In the MTT assay, 
TEM sample preparation
Cell preparation: the ZnO exposed cells (1000 g/ml; EZ-1 exposed for 1 h, EZ-3 exposed for 6 h) were harvested and placed in fixative (2% glutaraldehyde and 2% formaldehyde in 100 mM PIPES buffer), washed in a buffer, then spun into pellets and fixed in 1% osmium tetroxide. Following dehydration by a series of ascending strength alcohols and washing with dry acetone, the specimens were infiltrated with TAAB resin which was polymerised at 60 o C for 24 h. Sections were cut from the polymerised block with a nominal thickness of 90 nm using an ultra-microtome (Leica Ultra-cut E) and placed on a copper grid (Agar Scientific).
Both stained (uranyl acetate and lead citrate) and unstained sections were examined by the TEM described previously.
Model Membrane Assays
Lipid vesicle leakage assays and quartz crystal microbalance measurements on solidsupported bilayer systems were conducted as described previously, 25 except that in this study a lipids mixture was used that represents the lipid composition of a typical eukaryotic plasma membrane, but without the sphingomyelin fraction (POPC:DOPE:DOPS:cholesterol in a 9:6:1:4 weight ratio).
Results

Characterisation and dissolution
A range of physico-chemical properties were characterised for all the ZnO NPs under study here (Table 1) . TEM was used to determine size and morphology of the samples: for EZ-1 the average near equiaxed particle length is 30±20 nm with the coating not detectable by TEM but identifiable by FTIR as an aliphatic polyether (Supporting Information, Figure S1 and S2); for the uncoated near equiaxed EZ-2, the average particle length is 40±20 nm; and for EZ-3, the average nano-needle size is 1000±500 nm in length and 120±60 nm in width.
Powder XRD was used to confirm crystallinity and to indicate (crystalline) phase purity; all samples exhibit the expected zincite phase. DLS measurements revealed NP agglomeration upon dispersion in water and cell culture media, with the uncoated NPs and nano-needles showing significant flocculation, while the polymer coated NPs remain well dispersed. The zeta potential for the coated NPs when dispersed in water is negative (-14 mV), whereas for the uncoated samples and nano-needles it is positive (5 and 19 mV respectively).
ICP-MS measurement of the soluble zinc supernatant of ZnO NP dispersions in water and cell culture media at NP concentrations of 100 g/mL (Table 1) indicate levels at the same order of magnitude to those first reported in water by Franklin et al. 26 and in media by Song et al. 9 We have previously shown that control of pH is absolutely essential, since a decrease of just 0.15 pH units implies a doubling of the free Zn 2+ concentration of a solution containing non-dissolved ZnO NPs. 7 It is important to note that for sodium bicarbonate buffered cell culture media, like DMEM, small changes in temperature and particularly CO 2 levels can lead to significant changes in solution pH. We have used the electroanalytical method AGNES in order to directly (i.e. without any prior separation steps) measure the free Table 1 ), despite concerns regarding the overestimation of Zn solubility by ICP-MS. 28 In addition, we have also measured dissolution kinetics by AGNES. At concentrations above 5.5 g/mL ZnO, uncoated NPs (including EZ-2) typically reach the thermodynamic solubility limit in equilibrium with ZnCO 3 within 3-6 h, whereas the coated ZnO NPs (EZ-1) approach this limit only after 48 h incubation ( Figure 1 , data points labelled with letters and Supplementary Information, Figure S4 ). In conclusion therefore, the addition of up to 5.5 g/mL ZnO NPs (70 M Zn) to DMEM leads to a relatively fast, full dissolution of ZnO (Figure 2 and Additional File, Table S1 ). The concentration of ZnSO 4 was adjusted to give the same Zn content as used in the assays with ZnO (i.e., ZnSO 4 was tested at the same Zn-molarity as ZnO). The cytotoxicity tests gave a wide range of responses, but some general observations can be made. First, the ZnO NPs are no more cytotoxic than the ZnSO 4 control. Second, the uncoated, equiaxed NPs (EZ-2) always induced a lower response than the other particles and this NP type was the only one tested to yield median lethal concentration (LC 50 ) values consistently higher than 100 g/mL for all cell types (Additional File, Table S1 ). In order to test if the composition of the culture medium had a significant effect, a third cell line was tested. Although HaCaT epithelial cells are typically grown in DMEM media, we have cultured them in RPMI media, which is a more phosphate-rich culture medium than DMEM and could therefore result in reprecipitation of the relatively insoluble, zinc phosphate hydrates, as suggested previously. 4, 5 In all but one case, the HaCaT cells incubated in RPMI are more sensitive to ZnO NPs than Based on the cytotoxicity results, the three cell lines were treated with ZnO NPs at concentrations up to 10 g/mL or 1 g/mL for HaCaT cells (significant cell death at higher concentrations hampers the interpretation of the assay results) to measure the induction of DNA damage using the Comet assay. 29 The results show a small, but significant increase in DNA damage compared to controls at concentrations of 10 g/mL ZnO for HT29 cells for the polymer coated NPs (EZ-1) and the uncoated nano-needles (EZ-3; Figure 3 ). For the HaCaT cells, only the polymer coated NPs (EZ-1) show an increase in DNA damage at 1 g/mL, while the A549 cells are not significantly affected by any of the NPs (Figure 3 ).
EZ-2 seems to have a much lower cytotoxicity than EZ-1 or EZ-3 and the Comet assay results suggest this is not due to differences in DNA damage. To study further the mechanism of cytotoxicity, we measured the intracellular Zn 2+ concentration in A549 cells upon addition of the three NP types. We note that this assay could not be done in DMEM, but is performed in an imaging buffer that does not contain carbonate or phosphate and does contain 1.5 mM 
Model Membrane Interaction
At exposure doses of 1 mg/mL, temporal cytoplasmic Zn 2+ concentrations suggest that the uncoated, equiaxed ZnO NPs (EZ-2) produce a similar response to ZnCl 2 solutions, while the polymer coated NPs (EZ-1) and uncoated nano-needles (EZ-3) follow a different pathway (Figure 4 ). TEM confirms incomplete cellular internalization for these latter two particle types ( Figures 5 and 6 ). In order to test if either response could be due to a strong interaction between the particles and the plasma membrane, the interaction of the NPs with model membranes was investigated.
First, to study whether the ZnO NPs can cause membrane disruption, vesicle-leakage assays were performed in DMEM. 400-nm diameter unilamellar vesicles composed of POPC:DOPE:DOPS:cholesterol (9:6:1:4 weight ratio) were loaded with an auto-quenching fluorescent dye and incubated with the NPs. Release of the dye from a vesicle results in a dilution of the fluorescent dye, raising the observed fluorescence intensity. Indeed, significant increases in fluorescence intensity were observed upon addition of all three NP types tested (EZ-1, 2 and 3), indicating some dye is released and the membrane integrity compromised (Figure 7a ). Increasing the exposure dose of all three NP types increased the release of dye, however the polymer coated NPs (EZ-1) provoked the highest leakage at all doses and at 100 g/ml compromised the majority of the vesicles (unlike the other two particle types that induced < 20% leakage at this ZnO dose).
To explore the relatively enhanced ability of the polymer coated NPs (EZ-1) to provoke vesicle leakage, the ability of these particles to bind to a lipid membrane was studied with a (Table 1) to resolve this uncertainty and we conclude that toxic pathways depend on the equilibrium solubility of the ZnO in the dispersion media plus, at relatively high concentrations or short incubation times, the surface coating and morphology of the NPs. We note that our analysis excludes the presence of serum proteins because these are known to interact with ZnO nanoparticles, enhancing membrane activity 30 yet the impact of serum concentration on the amount of cellular uptake and the biological response to the exposure, is not fully understood (see for example 23 ).
Up to 5.5 g/mL of ZnO (70 M Zn), the particles fully dissolve in DMEM (albeit at a slower rate if polymer coated), while above this concentration, insoluble ZnCO 3 (smithsonite)
is most likely formed (Figure 1 ). This stable equilibrium applies to appropriately buffered cell culture media and is in broad agreement with previous work on less well buffered systems. particulates, or whether some ZnO NPs are retained with a carbonate coating. Regardless, above the zinc carbonate equilibrium concentration, phase transformed, lower solubility particles will be retained during cellular exposure, consistent with previous observations. 4, 5 We show that, uncoated, equiaxed ZnO NPs (EZ-2) induce a drop in cell viability at concentrations well above those of ZnSO 4 solutions in three different epithelial cell lines (Figure 2 and Supporting Information, Table S1 ). The higher cytotoxic response of ZnSO 4 compared to EZ-2 could be because additions of ZnSO 4 can lead to supersaturation of Zn 2+ with respect to the zinc carbonate equilibrium solubility of DMEM, as has been observed in our solubility experiments (Figure 1 ). This would imply that the zinc carbonate particulates are less cytotoxic than dissolved Zn 2+ . Also the polymer coated ZnO NPs and uncoated nanoneedles (EZ-1 and 3, respectively) do not exhibit a more acute cytotoxicity than that of ZnSO 4 ( Figure 2 ). However, they do provoke a significantly stronger response than EZ-2,
suggesting that the coating and the morphology affect cytotoxicity. EZ-1 and EZ-3 are able to induce a steady rise in intracellular Zn 2+ to concentrations above that of EZ-2 or ZnSO 4 ( Figure 4) . TEM confirms the cellular uptake of partially dissolved, polymer coated ZnO NPs and uncoated nano-needles ( Figures 5 and 6 , respectively). The nano-needles (EZ-3) readily flocculate upon dispersion in cell culture media (Table 1) such that sedimentation and rapid contact with cell membranes will occur during exposure but even so, they are incompletely internalised ( Figure 6 ). We suggest that this incomplete or frustrated cellular uptake contributes to the acute cell viability response ( Figure 2) ; uptake of ZnO nano-needles has been shown in human macrophage monocyte cells 13 but A549 cells are not normally phagocytic and may struggle to complete endocytic internalisation of such large needle agglomerates (Table 1) . Frustrated cellular uptake is an established phenomenon for fibres in general. 31 Endocytic cellular uptake of the polymer coated ZnO NPs (EZ-1) however, does not appear to be frustrated ( Figure 5 ) and is consistent with the slower dissolution rate of these NPs (Figure 1 and Figure S4 ). Additional experiments with model membranes confirm that EZ-1 binds to lipid membranes, possibly promoting endocytic uptake and raising intracellular Zn 2+ ( Figure 7) . Alternatively, our vesicle leakage assay shows that EZ-1 has a disrupting effect on the membrane, thus it cannot be excluded that EZ-1 compromises the plasma membrane, thereby allowing ZnO and Zn 2+ to passively enter the cell. It is currently not clear whether the aliphatic polyether polymer coat of EZ-1 is responsible for disrupting the lipid or whether a stable colloid suspension of ZnO is more damaging than agglomerates of ZnO/ZnCO 3 NPs. It has been shown recently however that the lipid membrane activity of ZnO NPs is enhanced in the presence of serum albumin because it forms a protein corona around the NPs. 30 It could be that the protein corona and aliphatic polyether polymer coating of EZ-1 have a common physical mechanism by which they impair the integrity of a lipid membrane.
Ultimately, it may be that exposing ZnO NPs to CO 2 rich atmospheres during the manufacture of ZnO NP products, to develop a ZnCO 3 coating, could mitigate much of the toxicity reported thus far. Obviously, any coating would have to not interfere significantly with the original performance properties of the NPs.
Conclusions
Overall, our data indicate the importance of understanding the role of the content of cell culture media used for testing the toxicity of ZnO NPs to cell lines in vitro. Cell viability (and induced DNA damage) depends on the equilibrium solubility of ZnO in the culture media (5.5 g/mL ZnO or 67 M Zn for dispersions in DMEM, held at pH 7.68). At NP concentrations well above the equilibrium solubility limit, ZnO NP morphology and surface coating are also factors. Polymer coatings that slow dissolution but promote strong interaction with lipid membranes will enhance the toxicity of ZnO NPs through increased cellular uptake followed by intracellular dissolution. In order to limit toxicity, surface coatings that prevent dissolution in these media, maintain NP dispersion and do not enhance interactions with cellular membranes should be sought. Similarly, needle-like morphologies also enhance the toxicity of ZnO NPs at high concentrations, by apparently frustrating cellular uptake. Thus, ZnO NP synthesis that avoids producing acicular morphologies is recommended. study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. We thank Prof. Alice Warley of the Centre for Ultrastructural Imaging, King's College London for enabling the preparation of thin sections for TEM.
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